Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene.

Journal: Leukemia & Lymphoma
Published:

Similar Publications

We couldn’t find any related articles. Please check for more on the main search page.